Age-Related Macular Degeneration treatment cost in Bangkok

Every treatment this condition maps to, cheapest first — diagnostics before treatments. Each links to its full price comparison. One pathway per patient; we never sum options into a fake total.

Each treatment links to its full price page — clinic prices, other cities, recovery and risks.

Your first spend is the work-up, not the treatment — the typical items, priced from this registry where we hold them.

Consultation fees from our specialist registry; procedure prices from this condition's mapped diagnostics. Unverified prices are labeled on their own pages.

The actual decision at this stage: the recurring cost of living with the condition vs the one-time treatment pathway. Unit prices only — we never extrapolate an annual total.

The go/no-go math everyone does on a napkin, done transparently: price here plus trip costs from United States (change in the header) — flying beats staying when your quote at home is above the line.

Trip = flights, hotel, transport and medication from the same model as the all-in estimates — labeled estimates, not quotes. If your quote at home is below the line, staying home wins on pure price; quality, waits and urgency are separate calls — see the MCI index above.

The same care market across the registry — cheapest entry first. Cheapest ≠ best: the MCI column grades each market as its data lands.

• Public-system wait at home (UK)NHS England referral-to-treatment statistics, Apr 2026 · Canada (CIHI) next 11.9-week median
• Recruiting age-related macular degeneration trials in ThailandClinicalTrials.gov — recruiting studies with a Thailand site Not yet sourced
• JCI-accredited organizations in ThailandJCI public directory, country-wide (all specialties) · 2026 ≈65

Cheapest entry price per city with the size of its priced treatment menu and specialist density — countable signals only, "—" is never guessed.

The best hospitals first — Newsweek World's Best national top 10 lead, then our connected-chain grade. Re-rank by rating or reviews.

Destination-safety factor for Thailand: ×0.90 — Level 2 — Exercise Increased Caution (unrest; deep-south provinces higher) (US State Dept Travel Advisory, 2026-07). Applies equally to every hospital here; it separates this market from higher-risk destinations.

Epidemiology slots — filled only from named registry sources, never estimated.

Having your existing diagnosis re-read here is the cheapest way to test a hospital's quality before booking anything. Prices land per hospital with sources — never estimated.

• Remote records review — written second opinion your existing scans, pathology and reports, reviewed without flying Not yet priced
• Video consultation with a specialist live case discussion after the review Not yet priced
• In-person specialist consultation reference price if you're already here Not yet priced

A second opinion changes the plan often enough that specialists expect to be asked for one — it's a normal request, not an insult. Remote-review prices are being collected per hospital.

How the treatment decision is typically made for this condition — your specialist confirms the path for your case.

1. 1

   See the right specialist

   Care for age-related macular degeneration starts with a ophthalmologist, who confirms the diagnosis and plans the next steps.

2. 2

   Diagnosis & tests

   The diagnosis is confirmed with Comprehensive Eye Exam, OCT (Optical Coherence Tomography) or Fundus Photography.

3. 3

   Treatment options

   Options include Intravitreal Injections — weighed on outcome, downtime, risk and total cost. See the priced menu and decision factors below.

4. 4

   Treatment or management

   The chosen option is carried out or the condition is managed — every option below links to its own price page with a recovery timeline.

5. 5

   Follow-up & monitoring

   Check-ups confirm the result and adjust treatment; remote follow-up is common for international patients.

Framework pathway modeled by field — per-condition clinical pathways replace it as they're sourced.

What actually decides between the treatments above — and the checklist an expert would put to the specialist.

A planning frame — suitability is always the specialist's call.

What matters if it goes wrong, and what it takes to get there — country-level, verifiable guidance in one place.

Visa

~93 nationalities (US, UK, EU, Australia) may enter visa-free for up to 60 days, extendable by 30 — but the visa-exemption scheme has been under review since May 2026, so confirm your nationality's current rule before travelling.

Medical / long-stay visa

For treatment longer than 60 days, a Medical Treatment (MT) e-Visa gives a 60–90 day stay with easier hospital-stay extensions; the Destination Thailand Visa (DTV) allows 180-day stays over 5 years.

Arrival

All arrivals must file the free Thailand Digital Arrival Card (TDAC) online within 72 hours of arrival.

Currency

Thai Baht (THB)

Languages

Thai; English widely spoken in international hospitals

Traveller safety

Generally safe

Legal recourse

Established malpractice recourse

Insurance

Medical-travel & complication cover widely available

International patients

Hospitals accustomed to international patients

General guidance from public sources — confirm current rules for your nationality. Verified against: Thailand visa exemption (2026) · Medical tourism visa & travel (2026).

One comparable grade for this city's care market for the diagnosis — treatment coverage, price, evidence, choice and provider trust on the same public formula. Unsourced metrics are excluded, never guessed.

Who treats age-related macular degeneration, and nearby diagnoses in the same field.

Dots carry the lens colors — teal opens a specialist page, red another condition, both priced for Bangkok.

Short answers built from the numbers on this page — costs, pathway, providers and verification.

How much of this page is verified data — every section carries a chip telling you where its numbers come from.